Abu-Raddad, L. J., Chemaitelly, H., Coyle, P., Malek, J. A., Ahmed, A. A., Mohamoud, Y. A., Younuskunju, S., Ayoub, H. H., Al Kanaani, Z., Al Kuwari, E., Butt, A. A., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul Rahim, H. F., Nasrallah, G. K., Yassine, H. M., Al Kuwari, M. G.…Bertollini, R . (2021). SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy. EClinicalMedicine, 35, 100861. https://doi.org/10.1016/j.eclinm.2021.100861
Google Scholar Addetia, A., Crawford, K. H. D., Dingens, A., Zhu, H., Roychoudhury, P., Huang, M. L., Jerome, K. R., Bloom, J. D., Greninger, A. L. (2020). Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with a high attack rate. Journal of Clinical Microbiology, 58(11). https://doi.org/10.1128/JCM.02107-20
Google Scholar Breathnach, A. S., Duncan, C. J. A., Bouzidi, K. E., Hanrath, A. T., Payne, B. A. I., Randell, P. A., Habibi, M. S., Riley, P. A., Planche, T. D., Busby, J. S., Sudhanva, M., Pallett, S. J. C., Kelleher, W. P. (2021). Prior COVID-19 protects against reinfection, even in the absence of detectable antibodies. Journal of Infection, 83(2), 237–279. https://doi.org/10.1016/j.jinf.2021.05.024
Google Scholar Cavanaugh, A., Spicer, K., Thoroughman, D., Glick, C., Winter, K. (2021). Reduced risk of reinfection with SARS-CoV-2 after COVID-19 vaccination—Kentucky, May–June 2021. Morbidity and Mortality Weekly Report (MMWR). https://doi.org/10.15585/mmwr.mm7032e1
Google Scholar Christie, A., Brooks, J. T., Hicks, L. A., Sauber-Schatz, E. K., Yoder, J. S., Honein, M. A., Team, C. C.-R. (2021). Guidance for implementing COVID-19 prevention strategies in the context of varying community transmission levels and vaccination coverage. Morbidity and Mortality Weekly Report (MMWR), 70(30), 1044–1047. https://doi.org/10.15585/mmwr.mm7030e2
Google Scholar Cohen, K. W., Linderman, S. L., Moodie, Z., Czartoski, J., Lai, L., Mantus, G., Norwood, C., Nyhoff, L. E., Edara, V. V., Floyd, K., De Rosa, S. C., Ahmed, H., Whaley, R., Patel, S. N., Prigmore, B., Lemos, M. P., Davis, C. W., Furth, S., O’Keefe, J. B.…McElrath, M. J . (2021). Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells. Cell Reports Medicine, 2(7), 100354. https://doi.org/10.1016/j.xcrm.2021.100354
Google Scholar Dong, E., Du, H., Gardner, L. (2020). An interactive web-based dashboard to track COVID-19 in real time. The Lancet Infectious Diseases, 20(5), 533–534. https://doi.org/10.1016/S1473-3099(20)30120-1
Google Scholar Gazit, S., Shlezinger, R., Perez, G., Lotan, R., Peretz, A., Ben-Tov, A., Cohen, D., Muhsen, K., Chodick, G., Patalon, T. (2021). Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: Reinfections versus breakthrough infections. medRxiv . https://doi.org/10.1101/2021.08.24.21262415
Google Scholar Goldberg, Y., Mandel, M., Woodbridge, Y., Fluss, R., Novikov, I., Yaari, R., Ziv, A., Freedman, L., Huppert, A. (2021). Protection of previous SARS-CoV-2 infection is similar to that of BNT162b2 vaccine protection: A three-month nationwide experience from Israel. medRxiv .
Google Scholar Hall, V. J., Foulkes, S., Charlett, A., Atti, A., Monk, E. J. M., Simmons, R., Wellington, E., Cole, M. J., Saei, A., Oguti, B., Munro, K., Wallace, S., Kirwan, P. D., Shrotri, M., Vusirikala, A., Rokadiya, S., Kall, M., Zambon, M., Ramsay, M.,…Group, S. S . (2021). SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: A large, multicentre, prospective cohort study (SIREN). Lancet, 397(10283), 1459–1469. https://doi.org/10.1016/S0140-6736(21)00675-9
Google Scholar Hansen, C. H., Michlmayr, D., Gubbels, S. M., Molbak, K., Ethelberg, S. (2021). Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: A population-level observational study. Lancet, 397(10280), 1204–1212. https://doi.org/10.1016/S0140-6736(21)00575-4
Google Scholar Harvey, R. A., Rassen, J. A., Kabelac, C. A., Turenne, W., Leonard, S., Klesh, R., Meyer, W. A., 3 rd, Kaufman, H. W., Anderson, S., Cohen, O., Petkov, V. I., Cronin, K. A., Van Dyke, A. L., Lowy, D. R., Sharpless, N. E., Penberthy, L. T. (2021). Association of SARS-CoV-2 seropositive antibody test with risk of future infection. JAMA Internal Medicine, 181(5), 672–679. https://doi.org/10.1001/jamainternmed.2021.0366
Google Scholar Jeffery-Smith, A., Iyanger, N., Williams, S. V., Chow, J. Y., Aiano, F., Hoschler, K., Lackenby, A., Ellis, J., Platt, S., Miah, S., Brown, K., Amirthalingam, G., Patel, M., Ramsay, M. E., Gopal, R., Charlett, A., Ladhani, S. N., Zambon, M. (2021). Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020. Euro Surveill, 26(5). https://doi.org/10.2807/1560-7917.ES.2021.26.5.2100092
Google Scholar Jin, H., Liu, J., Cui, M., Lu, L. (2020). Novel coronavirus pneumonia emergency in Zhuhai: Impact and challenges. Journal of Hospital Infection, 104(4), 452–453. https://doi.org/10.1016/j.jhin.2020.02.005
Google Scholar Kojima, N., Roshani, A., Brobeck, M., Baca, A., Klausner, J. D. (2021). Incidence of severe acute respiratory syndrome coronavirus-2 infection among previously infected or vaccinated employees. medRxiv . https://doi.org/10.1101/2021.07.03.21259976
Google Scholar Leidi, A., Berner, A., Roxane, D., Dubos, R., Koegler, F., Piumatti, G., Vuilleumier, N., Kaiser, L., Balavoine, J. F., Trono, D., Pittet, D., Chappuis, F., Kherad, O., Courvoisier, D., Azman, A. S., Zaballa, M. E., Guessous, I., Stringhini, S. (2021). Occupational risk of SARS-CoV-2 infection and reinfection during the second pandemic surge: A cohort study. medRxiv . https://doi.org/10.1101/2021.08.06.21261419
Google Scholar Leidi, A., Koegler, F., Dumont, R., Dubos, R., Zaballa, M. E., Piumatti, G., Coen, M., Berner, A., Darbellay Farhoumand, P., Vetter, P., Vuilleumier, N., Kaiser, L., Courvoisier, D., Azman, A. S., Guessous, I., Stringhini, S., & Group, S. E.-P. S . (2021). Risk of reinfection after seroconversion to SARS-CoV-2: A population-based propensity-score matched cohort study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciab495
Google Scholar | Crossref | Medline Letizia, A. G., Ge, Y., Vangeti, S., Goforth, C., Weir, D. L., Kuzmina, N. A., Balinsky, C. A., Chen, H. W., Ewing, D., Soares-Schanoski, A., George, M. C., Graham, W. D., Jones, F., Bharaj, P., Lizewski, R. A., Lizewski, S. E., Marayag, J., Marjanovic, N., Miller, C. M…Sealfon, S. C . (2021). SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: A prospective cohort study. The Lancet Respiratory Medicine. https://doi.org/10.1016/S2213-2600(21)00158-2
Google Scholar Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hrobjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S.…Moher, D . (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71
Google Scholar Pilz, S., Chakeri, A., Ioannidis, J. P., Richter, L., Theiler-Schwetz, V., Trummer, C., Krause, R., Allerberger, F. (2021). SARS-CoV-2 re-infection risk in Austria. European Journal of Clinical Investigation, 51(4), e13520. https://doi.org/10.1111/eci.13520
Google Scholar Pouwels, K. B., Pritchard, E., Matthews, P. C., Stoesser, N., Eyre, D. W., Vihta, K. -D., House, T., Hay, J., Bell, J. I., Newton, J. N., Farrar, J., Crook, D., Cook, D., Rourke, E., Studley, R., Peto, T., Diamond, I., Walker, A. S., & Team, C.-I. S . (2021). Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK. Nuffield Department of Medicine. https://doi.org/10.1101/2021.08.18.21262237
Google Scholar Qureshi, A. I., Baskett, W. I., Huang, W., Lobanova, I., Naqvi, S. H., Shyu, C. R. (2021). Re-infection with SARS-CoV-2 in patients undergoing serial laboratory testing. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciab345
Google Scholar Rennert, L., McMahan, C. (2021). Risk of SARS-CoV-2 reinfection in a university student population. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciab454
Google Scholar Rouse, B. T., Sehrawat, S. (2010). Immunity and immunopathology to viruses: What decides the outcome? Nature Reviews Immunology, 10(7), 514–526. https://doi.org/10.1038/nri2802
Google Scholar Sheehan, M. M., Reddy, A. J., Rothberg, M. B. (2021). Reinfection rates among patients who previously tested positive for COVID-19: A retrospective cohort study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciab234
Google Scholar Shrestha, N. K., Burke, P. C., Nowacki, A. S., Terpeluk, P., Gordon, S. M. (2021). Necessity of COVID-19 vaccination in previously infected individuals. medRxiv . https://www.medrxiv.org/content/10.1101/2021.06.01.21258176v2
Google Scholar Stephens, D. S., McElrath, M. J. (2020). COVID-19 and the path to immunity. JAMA, 324(13), 1279–1281. https://doi.org/10.1001/jama.2020.16656
Google Scholar Thompson, M. G., Burgess, J. L., Naleway, A. L., Tyner, H. L., Yoon, S. K., Meece, J., Olsho, L. E. W., Caban-Martinez, A. J., Fowlkes, A., Lutrick, K., Kuntz, J. L., Dunnigan, K., Odean, M. J., Hegmann, K. T., Stefanski, E., Edwards, L. J., Schaefer-Solle, N., Grant, L.…Gaglani, M . (2021). Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and other essential and frontline workers—Eight U.S. locations, December 2020–March 2021. Morbidity and Mortality Weekly Report (MMWR), 70(13), 495–500. https://doi.org/10.15585/mmwr.mm7013e3
Google Scholar Vitale, J., Mumoli, N., Clerici, P., De Paschale, M., Evangelista, I., Cei, M., Mazzone, A. (2021). Assessment of SARS-CoV-2 reinfection 1 year after primary infection in a population in Lombardy, Italy. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2021.2959
Google Scholar